Correlation Between Novartis and Ono Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Novartis and Ono Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novartis and Ono Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novartis AG ADR and Ono Pharmaceutical Co, you can compare the effects of market volatilities on Novartis and Ono Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novartis with a short position of Ono Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novartis and Ono Pharmaceutical.
Diversification Opportunities for Novartis and Ono Pharmaceutical
0.93 | Correlation Coefficient |
Almost no diversification
The 3 months correlation between Novartis and Ono is 0.93. Overlapping area represents the amount of risk that can be diversified away by holding Novartis AG ADR and Ono Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ono Pharmaceutical and Novartis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novartis AG ADR are associated (or correlated) with Ono Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ono Pharmaceutical has no effect on the direction of Novartis i.e., Novartis and Ono Pharmaceutical go up and down completely randomly.
Pair Corralation between Novartis and Ono Pharmaceutical
Considering the 90-day investment horizon Novartis AG ADR is expected to generate 0.39 times more return on investment than Ono Pharmaceutical. However, Novartis AG ADR is 2.6 times less risky than Ono Pharmaceutical. It trades about -0.25 of its potential returns per unit of risk. Ono Pharmaceutical Co is currently generating about -0.22 per unit of risk. If you would invest 10,991 in Novartis AG ADR on August 31, 2024 and sell it today you would lose (504.00) from holding Novartis AG ADR or give up 4.59% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Novartis AG ADR vs. Ono Pharmaceutical Co
Performance |
| Timeline |
| Novartis AG ADR |
| Ono Pharmaceutical |
Novartis and Ono Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Novartis and Ono Pharmaceutical
The main advantage of trading using opposite Novartis and Ono Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novartis position performs unexpectedly, Ono Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ono Pharmaceutical will offset losses from the drop in Ono Pharmaceutical's long position.| Novartis vs. AstraZeneca PLC ADR | Novartis vs. GlaxoSmithKline PLC ADR | Novartis vs. Roche Holding Ltd | Novartis vs. Bristol Myers Squibb |
| Ono Pharmaceutical vs. Santen Pharmaceutical Co | Ono Pharmaceutical vs. GSK plc | Ono Pharmaceutical vs. Grifols SA ADR | Ono Pharmaceutical vs. Pfizer Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |